NasdaqGS - Delayed Quote USD

GoodRx Holdings, Inc. (GDRX)

Compare
7.86 -0.04 (-0.51%)
At close: September 3 at 4:00 PM EDT
7.86 0.00 (0.00%)
After hours: September 3 at 5:20 PM EDT
Loading Chart for GDRX
DELL
  • Previous Close 7.90
  • Open 7.85
  • Bid 7.86 x 300
  • Ask 7.89 x 600
  • Day's Range 7.78 - 7.95
  • 52 Week Range 4.14 - 9.26
  • Volume 1,002,892
  • Avg. Volume 1,441,790
  • Market Cap (intraday) 2.998B
  • Beta (5Y Monthly) 1.39
  • PE Ratio (TTM) --
  • EPS (TTM) -0.14
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.53

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

www.goodrx.com

694

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GDRX

View More

Performance Overview: GDRX

Trailing total returns as of 9/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GDRX
17.31%
S&P 500
15.91%

1-Year Return

GDRX
20.00%
S&P 500
22.44%

3-Year Return

GDRX
80.22%
S&P 500
21.86%

5-Year Return

GDRX
83.17%
S&P 500
70.81%

Compare To: GDRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GDRX

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    3.00B

  • Enterprise Value

    3.18B

  • Trailing P/E

    --

  • Forward P/E

    24.39

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.08

  • Price/Book (mrq)

    4.48

  • Enterprise Value/Revenue

    4.10

  • Enterprise Value/EBITDA

    29.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.57%

  • Return on Assets (ttm)

    1.88%

  • Return on Equity (ttm)

    -7.50%

  • Revenue (ttm)

    775.09M

  • Net Income Avi to Common (ttm)

    -58.68M

  • Diluted EPS (ttm)

    -0.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    524.9M

  • Total Debt/Equity (mrq)

    105.67%

  • Levered Free Cash Flow (ttm)

    56.82M

Research Analysis: GDRX

View More

Company Insights: GDRX

Research Reports: GDRX

View More

People Also Watch